Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems

Journal of Controlled Release

Volumn 4, Issue 3, 1986, Pages 155-180

  Holland, Simon J ^a   Tighe, Brian J ^a   Gould, Philip L ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIOXANE DERIVATIVE; BIOPOL; POLY(3 HYDROXYBUTYRIC ACID); POLYANHYDRIDE; POLYDIOXANONE; POLYESTER; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; UNCLASSIFIED DRUG;

DEGRADATION; DRUG FORMULATION; DRUG RELEASE; HYDROXYBUTYRIC ACID DERIVATIVE; HYDROXYVALERIC ACID; NONHUMAN; POLYCAPROLACTONE; POLYLACTONE; POLYOXALATE; POLYVALEROLACTONE; PRIORITY JOURNAL; REVIEW; SUSTAINED RELEASE PREPARATION; SUTURE;

EID: 0022975567     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(86)90001-5     Document Type: Article

References (185)

1. Polymeric delivery systems for controlled drug release
2. Present and future applications of biomaterials in controlled drug delivery systems
3. Chemical and physical structure of polymers as carriers for controlled release of bioactive agents A review
4. Biodegradable polymers in controlled drug delivery
5. Synthesis of biodegradable polymers for biomedical utilization
6. Controlled release of water soluble macromolecules from bioerodible hydrogels
7. Controlled release and magnetically modulated systems for macromolecular drugs
8. Polymer based drug delivery: Magnetically modulated and bioerodible systems
9. An explanation for the controlled release of macromolecules from polymers
10. Macromolecular release from a bioerodible implant
11. A new absorbable suture
12. Biodegradable plastic containers for seedling transplants
13. Zeroorder controlled release polymeric matrices for micro- and macromolecules
14. In vivo and in vitro release of macromolecules from polymeric drug delivery systems
15. Biocompatibility of polymeric delivery systems for macromolecules
16. Experimental approaches for achieving both zero order and modulated controlled release from polymer matrix systems
17. Polymers for the controlled release of macromolecules: Effect of molecular weight of ethylene-vinyl acetate copolymer
18. Controlled release of macromolecules: Biological studies
19. Polymers for the controlled release of macromolecules: Effect of vinyl acetate content of ethylene-vinyl acetate copolymer
20. Alcap ceramics in drug delivery
21. Mechanisms of solute release from porous hydrophilic polymers
22. Novel erodible polymers for the delivery of macromolecules
23. Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels
24. Effect of initially non-uniform concentration distribution on the kinetics of drug release from glassy polymers
25. Kinetics of drug release from glassy polymers: Effect of initially nonuniform drug distribution
26. The role of polymer matrix structure and interparticle interactions in diffusion limited drug release
27. Swelling activated erodible systems for an in vitro programmed zero order release
28. Controlled release from matrices of different shape and nature
29. The megaloporous system: A novel principle for zero-order drug delivery
30. Biodegradation of surgical polymers
31. Biodegradable drug delivery systems based on aliphatic polyesters: Application to contraceptives and narcotic antagonists
32. The design of biodegradable polymers: Two approaches
33. Biodegradable polymers, Biocompat
34. Hydrogels and biodegradable polymers for the controlled delivery of drugs
35. Synthetic polymers and the living environment
36. Quantitative aspects of polymer degradation in the living body
37. Controlled drug release by ultrasound irradiation
38. Ultrasonically controlled delivery systems
39. Controlled release of biologically active compounds from bioerodible polymers
40. Polymers for sustained macromolecular release: Procedures to fabricate reproducible delivery systems and controlled release kinetics
41. Biodegradable systems for the sustained release of fertility-regulating agents
42. Mechanisms for the sustained release of biologically active agents
43. Enzyme—polymer interactions
44. Polydioxanone (PDS), a novel monofilament synthetic absorbable suture
45. Poly(lactic acid) and poly (lactic acid-co-glycolic acid) contraceptive delivery systems
46. Poly-d(−)-3-hydroxybuttersäure (PHB) — ein biologisch abbaubarer Arzneistoffträger zur Liberations-verzögerung. 2. Mitt.: Über die biologische Abbaubarkeit im tierischen Organismus und die in-vitro-in-vivo-Korrelation der Arznei-stoffliberation aus parenteral applizierbaren Matrix-Retardtabletten
47. Enzyme-accelerated hydrolysis of poly gly colic acid
48. An in vitro study of the effect of buffer on the degradation of poly(glycolic acid) sutures
49. Approach to the numerical quantitation of acute tissue response to biomaterials
50. Polyglycolic acid sutures, laboratory and clinical evaluation of a new absorbable suture material
51. Some observations on the role of cellular enzymes in the in-vivo degradation of polymers
52. In vivo and in vitro studies of biodegradable polymers for use in medicine and surgery
53. Enzyme hydrolysis of polylactic acid
54. Polycaproamide degradation in rabbits and in several model media
55. Cellular enzymes activity at the polymer—tissue interface A review
56. Polyglactin 910 suture absorption and the role of cellular enzymes
57. The intracellular degradation of poly(ϵ-caprolactone)
58. Biodegradable elastomeric polyesters
59. Biodegradation of some biomaterials in vitro
60. Synthetic polymers and the living environment
61. The degradation of a synthetic polyester by a lysomal enzyme
62. The effects of lipids on the mechanical properties of polyglycolic acid sutures
63. Mechanism of the biodégradation of polycaprolactone
64. The effect of bacteria on absorbable sutures
65. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres
66. Degradation phenomena of two linear aliphatic polyester fibres used in medicine and surgery
67. Scanning electron microscopic study of the hydrolytic degradation of poly(glycolic acid) suture
68. Biodegradable polymers for use in surgery — Poly(glycolic)/ poly(lactic acid) homo- and copolymers 1
69. The in vitro degradation of poly(glycolic acid) sutures — Effect of pH
70. Hydrolytic degradation of polyglycolic acid: Tensile strength and crystallinity study
71. A comparison of the effect of pHon the biodegradation of two synthetic absorbable sutures
72. An in vitro evaluation of the stability of mechanical properties of surgical suture materials in various pH conditions
73. The effect of annealing treatments on the mechanical and degradative properties of polyglycolic acid sutures
74. Biodegradable polymers for use in surgery — Poly(glycolic)/poly (lactic acid) homo- and copolymers. 2: in vitro degradation
75. Biodegradable polymers
76. Degradation rates of oral resorbable implants (polylactates and polyglycolates) : Rate modification with changes in PLA/PGA copolymer ratios
77. Bioresorbable plastic materials for bone surgery
78. Melt spinning of poly-l-lactide and hydrolysis of the fibre in vitro
79. Aliphatic polyesters. 2. The degradation of poly(d,l-lactide), poly(ϵ-caprolactone) and their copolymers In vivo
80. The design of controlled drug delivery systems based on biodegradable polymers
81. Resorption rate, route of elimination, and ultrastructure of implant site of polylactic acid in the abdominal wall of the rat
82. Biodegradable hollow fibres for the controlled release of drugs
83. Sustained drug delivery systems. II: Factors affecting release rates from poly(ϵ-caprolactone) and related biodegradable polyesters
84. Long term controlled delivery of levonorgestrel in rats by means of small biodegradable cylinders
85. The effect of hydrocortisone acetate loaded poly(d, l-lactide) films on the inflammatory response
86. Characterisation of drug-loaded poly(d,l-lactide) microspheres
87. Biodegradable microspheres for prolonged local anesthesia
88. Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly(d,l-lactide)
89. A high strength absorbable polymer for internal bone fixation
90. Fall Meeting
91. Synthetic Fibre Forming Polymers
92. Morphological and structural changes in a copolymer of glycolide and lactide occurring as a result of hydrolysis
93. The effect of pH on the in vitro degradation of poly(glycolide-lactide) copolymer absorbable sutures
94. Biodegradable polymers and sustained delivery of contraceptive drugs
95. Basis for design of biodegradable polymers for sustained release of biologically active agents
96. An injectable sustained release fertility control system
97. Sustained release of a dual antimalarial system
98. Biopolymer system design for sustained release of biologically active agents
99. Development of drug delivery systems for use in treatment of narcotic addiction — A culmination
100. Biodegradable cylindrical implants for fertility control
101. Poly(d,l-lactide-co-glycolide)/norethisterone microcap-sules clinical study
102. Three and six month controlled release testosterone microcapsules
103. Clinical evaluation of an absorbable polymer injectable contraceptive system
104. Long-acting steroid microcapsules for parenteral administration
105. Controlled release of GNRH analogue from injected polymeric microcapsules: Formulation characteristics
106. Poly(lactic-co-glycolic) acid: Properties and performance in controlled release delivery systems of LHRH analogues
107. Controlled delivery of an LHRH analogue from biodegradable injectable microspheres
108. Biodegrad able polymers for the sustained release of peptides
109. A new synthetic monofilament absorbable suture made from polytrimethylen carbonate
110. Absorbable ligating clips
111. The use of mebendazole and levamisole in sustained release formulations
112. Aliphatic polyesters. 1. The degradation of poly(ϵ-caprolactone) in vivo
113. Microbial degradation of polyesters Polycaprolactone degraded by P pullulans
114. Capronor — A biodegradable delivery system for levonorgestrel
115. Biodegradable implants: Alternative approaches
116. Biodegradable polymers for sustained drug delivery
117. Biodegradable polymers for parenteral administration
118. Absorbable fibres of ϵ -caprolactone/glycolide copolymers and their biological properties
119. Fibrous delivery Systems for antimicrobial agents
120. The enzymatic surface erosion of aliphatic polyesters
121. Biodegradable polymers
122. Poly-D(-)-3-hydroxybuttersäure (PHB) — ein biologisch abbaubarer Arzneistoffträger zur Liberationsverzögerung. 1. Mitt.: Eintwicklung von parenteral applizierbaren Matrixtabletten zur Langzeitabgabe von Arzneistoffen
123. Poly((3-hydroxy-butyric acid), naturally occurring thermoplastic material
124. The thermal degradation of poly(-(d)-β-hydroxy-butyric acid). Part 1. Identification and quantitative analysis of products
125. Biodegradable polymers in medicine and surgery
126. The thermal degradation of poly(-(d)-β-hydroxy-butyric acid). Part 2. Changes in molecular weight
127. The thermal degradation of poly(-(d)-)-β-hydroxy-butyric acid). Part 3. The reaction mechanism
128. Extracellular enzyme secretion by Pseudomonas lemoignei
129. Poly-d(−)-3-hydroxybuttersäure — ein biologisch abbau-barer Arzneistoffträger zur Liberationsverzögerung. 3. Mitt.: Gewebsverträglichkeitsstudien parenteral applizierbarer Poly-d(—)-3-hydroxy-buttersaure-Tabletten in Gewebekultur und In vivo
130. Applications of PHB — a microbially produced biodegradable thermoplastic
131. in vitro and In vivo evaluation of CCNU-loaded microspheres prepared from poly((+)-lactide) and poly(β-hydroxybutyrate)
132. Fate and effect of CCNU-loaded microspheres made of poly(d,l)lactide (PLA) or poly β-hydroxy-butyrate (PHB) in mice
133. The thermal degradation of polyalpha-esters
134. Poly(β-malic acid) as a source of polyvalent drug carriers: Possible effects of hydrophobic substituents in aqueous media
135. Le poly(β-acide malique): Un polyester functionnalisé d'intérêt pharmacologique
136. Polyesters from Krebs cycle monomers as vehicles for sustained release
137. Synthesis and biodegradation of polymers derived from alpha hydroxy acids
138. Bioerodable polyanhydrides for controlled drug delivery
139. Bioerodible polyanhydrides as a drug carrier matrix
140. Bioerodible polyanhydrides for controlled drug delivery
141. Macromolecular drug release from biodegradable polyanhydride microsphers
142. Drug delivery from catalysed erodible polymeric matrices of poly(ortho esters)
143. Controlled release from erodible poly(ortho ester) drug delivery systems
144. Controlled release of contraceptive agents from poly(ortho esters)
145. Controlled drug release from poly-(ortho esters)
146. in vitro and In vivo release of levonor-gestrel from poly(ortho esters), 1. Linear polymers
147. in vitro and In vivo release of levonor-gestrel from poly(ortho esters). 2. Crosslinked polymers
148. Controlled drug release from poly(ortho esters) — A surface eroding polymer
149. biomedical applications of polysaccharides
150. Synthesis and characterisation of some modified polysaccharides containing drug moieties
151. A new simple controlled release delivery system
152. Carbohydrate matrixes for slow release; in vitro and In vivo results
153. Synthesis of biodegradable addition polymers
154. in vitro and In vivo studies of drug-releasing poly(amino acids)
155. A new approach to the development of bioerodible polymers for controlled release applications employing naturally occurring amino acids
156. Non-peptide poly(amino acids) for biodegradable drug delivery systems
157. Biodegradable drug delivery systems based on polypeptides
158. Biodegradable soluble synthetic polymers as drug carriers
159. Alginate/poly-l-lysine microcapsules as a vehicle for controlled release of macromolecules
160. Hydrolysis of crosslinked polyester polyurethanes